Diffuse electroencephalogram slowing in psychiatric patients: A preliminary report

Journal of Psychiatry and Neuroscience

Volumn 21, Issue 4, 1996, Pages 259-263

  Boutros, Nashaat N ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Diffuse slowing; EEG; Inpatients; Psychiatry; Psychotropic medications

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; LENGTH OF STAY; MALE; MENTAL DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AGED; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHOTROPIC DRUGS;

EID: 0030188780     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Brenner RP, Reynolds CF, Ulrich RF. 1989. EEG finding in depressive pseudodementia and dementia with secondary depression. Electroencephalogr Clin Neurophysiol 72:298-304.
2. Dasberg H, Robinson S. 1971. Electroencephalographic variations following antipsychotic drug treatment: diagnostic and prognostic significance. Dis Nerv Sys July:472-8.
3. Engel GL, Romano J. 1944. Delirium: I, EEG data. Arch Neurol Psychiatry 51:356-92.
4. Engel GL, Romano J. 1959. Delirium, a syndrome of cerebral insufficiency. J Chronic Dis 9:260-77.
5. Fink M. 1969. EEG and human psychopharmacology. Ann Rev Pharmacol 9:241-58.
6. Galderisi S, Maj M, Mucci A, Bucci P, Kemali D. 1994. QEEG alpha 1 changes after a single dose of high-potency neuroleptic as a predictor of short-term response to treatment in schizophrenic patients. Biol Psychiatry 35:367-74.
7. Galderisi S, Mucci A, Mignone ML, Maj M, Kemali D. 1992. QEEG mapping in drug-free schizophrenics: differences from healthy subjects and changes induced by haloperidol treatment. Schizophr Res 6:15-24.
8. Johnson G, Maccario M, Gershon S, Korein J. 1970. The effects of lithium on electroencephalogram behavior and serum electrolytes. J Nerv Ment Dis 151:273-89.
9. Lifshitz K, Gradijan J. 1974. Spectral evaluation of the electroencephalogram: power and variability in chronic schizophrenic and normal subjects. Psychophysiology 11:479-90.
10. Matsuura M, Yoshino M, Ohta K, Onda H, Nakajima K, Kojima T. 1994. Clinical significance of diffuse delta EEG activity in chronic schizophrenia. Clin Electroencephalogr 25:115-21.
11. Mellerio F. 1964. Electroencephalographie dans les intoxications aiguës. Paris: Masson.
12. Saletu B, Kufferle B, Grunberger J, Foldes P, Topitz A, Anderer P. 1994. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine. Neuropsychobiology 29:125-35.
13. Schellenberg R, Milch W, Schwarz A, Schober F, Dimpfe W. 1994. Quantitative EEG and BPRS data following haldoldecanoate administration in schizophrenics. Int Clin Psychopharmacol 9:17-24.
14. Struve FA. 1994. Selective referral versus routine screening in clinical EEG assessment of psychiatric inpatients. Psychiatr Med 4:317-43.
15. Welch J, Manschreck T, Redmong D. 1994. Clozapine-induced seizures and EEG changes. J Neuropsychiatry Clin Neurosci 6:250-6.
16. Westphal KP, Grozinger B, Diekmann V, Reeb W, Leibing W, Kornhuber HH. 1990. Slower theta activity over the midfrontal cortex in schizophrenic patients. Acta Psychiatr Scand 81:132-238.
17. Wise MG, Brandt GT. 1992. Delirium. In: Yudofsky SC, Hales RE, editors. The American Psychiatric Press text-book of neuropsychiatry. 2nd ed. Washington (DC): American Psychiatric Press, p 291-310.